Business Description
NRx Pharmaceuticals is a drug development company focused on creating new treatments for serious mental health conditions, including severe depression, PTSD, and chronic pain. The company is advancing two key medicines: one that combines two existing compounds into a single oral pill for patients with bipolar depression and suicidal thoughts, and another that delivers ketamine through an IV drip for similar cases. Founded in 2015 and based in Wilmington, Delaware, NRx works with several partner organizations and holds multiple licensing agreements to support its research and bring its treatments to market.
